Abstract: This study examined whether sleep disturbance predicted or moderated responses to psychotherapy in participants who participated in STEP-BD, a national, multisite study that examined the effectiveness of different treatment combinations for bipolar disorder. Participants received either a brief psychosocial intervention called collaborative care (CC; n = 130) or intensive psychotherapy (IP; n = 163), with study-based pharmacotherapy. Participants (N = 243) were defined as current (past week) short sleepers (<6 hours/night), normal sleepers (6.5-8.5 hours/night), and long sleepers (≥9 hours/night), according to reported average nightly sleep duration the week before randomization. Sleep disturbances did not predict the likelihood of recovery nor time until recovery from a depressive episode. There was no difference in recovery rates between IP versus CC for normal sleepers, and medium effect sizes were observed for differences in short and long sleepers. In this study, sleep did not play a major role in predicting or moderating response to psychotherapy in bipolar disorder.
B ipolar disorder is a severe psychiatric illness characterized by episodes of mood elevation and depression. Individuals with this disorder have significant functional impairment, reduced quality of life, and a high risk of suicidality (Kilbourne et al., 2004; Novick et al., 2010) . Pharmacotherapy is considered the foundation of treatment for this chronic disorder (Geddes and Miklowitz, 2013) ; however, use of medications alone often fails to bring patients to full and sustained remission (Frank et al., 2000) . The limited efficacy of pharmacotherapy alone highlights the need for adjunctive psychosocial interventions (Lauder et al., 2010) .
When psychotherapy is paired with pharmacotherapy, participants experience reduced rates of relapse, improved medication adherence, reduced residual mood symptoms, and improved overall psychosocial functioning Miklowitz, 2008; Otto and Miklowitz, 2004) . However, there is considerable variability in response rates in clinical trials of psychotherapy, pointing to the need to identify moderators of treatment response.
Sleep disturbance is a common prodromal feature of bipolar disorder and a precipitant of mood episodes (Jackson et al., 2003) . Sleep disturbance often precedes the onset of both manic and depression symptoms, and it worsens after episode onset (Bauer et al., 2006; Colombo et al., 1999; Harvey et al., 2005; Jackson et al., 2003) . Moreover, during mood episodes, short sleep duration, which is indicative of insomnia, is associated with more severe symptoms, and both short and long sleep duration are associated with poorer functioning and quality of life. Sleep disturbance is also present during periods of relative remission (Harvey et al., 2005) . Psychotherapy (e.g., cognitive behavioral therapy, interpersonal psychotherapy) is associated with decreased rapid eye movement (REM) density in individuals with unipolar depression (Buysse et al., 1997; Nofzinger et al., 1994) . During remission, instability in sleep and biological rhythms are correlated with levels of the disability in bipolar disorder (Giglio et al., 2010) .
To better understand the role of sleep in treatment outcomes for bipolar disorder, the current study investigated whether sleep disturbance (defined as shorter or longer sleepers) mediates or moderates the likelihood that patients recover from depression in response to intensive psychotherapy or collaborative care in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). STEP-BD, a National Institute of Mental Health-sponsored study of the effectiveness of treatments for bipolar disorder, found that adjunctive, intensive psychotherapy, as compared to brief psychoeducation (collaborative care), was more beneficial in achieving and reducing time to recovery from a depressive episode (Miklowitz et al., 2007) . We hypothesized that (1) STEP-BD participants who are normal sleepers will have higher recovery rates from mood episodes and will recover in less time compared to short or long sleepers; and (2) individuals with sleep disturbance (i.e., short or long sleepers) would be more likely to achieve recovery with intensive psychotherapy than with collaborative care.
METHOD Study Design
STEP-BD was a national, multisite study that examined the effectiveness of different treatment combinations for symptoms of bipolar disorder, including various pharmacotherapy and psychosocial interventions. STEP-BD was the largest longitudinal treatment outcome study in bipolar disorder, enrolling 4361 subjects across 21 sites (Sachs et al., 2003) . Ethical approval was obtained by each site's respective human research committee (Sachs et al., 2003) . Individuals in STEP-BD, who were currently in a depressive episode, were offered to participate in a randomized control trial comparing adjunctive intensive psychotherapy to a control group in 15 clinics (Miklowitz et al., 2007) . In this trial, participants, after giving additional written informed consent, were randomly assigned to either 6 weeks of treatment (up to 3 sessions) with collaborative care (CC; N = 130) or 9 months of weekly (Miklowitz et al., 2007) .
Collaborative care was a brief intervention that focused on psychoeducation about bipolar disorder and employed some of the most common psychosocial strategies shown to be beneficial for bipolar disorder (Miklowitz et al., 2007) . CBT emphasized challenging negative thoughts and dysfunctional beliefs, cognitive restructuring, and problem solving training (Lam et al., 2005) . FFT focused on educating the participants' family members about bipolar disorder and the family unit's impact on the illness course. It also emphasized improving communication and problem solving in the home environment (Miklowitz et al., 2000) . IPSRT stressed the importance of social rhythm stability for prevention of mood disruptions by developing plans for mood and social rhythm stability, and learning strategies to manage interpersonal conflicts such as grief, relationship difficulties, or role disputes (Frank et al., 2000 (Frank et al., , 2005 .
Participants
Participants (n = 293) were eligible for the study if they met DSM-IV criteria for bipolar I or II disorders and a current major depressive episode, and were currently being treated or willing to be treated with a mood stabilizer. If participants were currently undergoing psychotherapy, they could enroll in the study if they discontinued nonstudy-related psychotherapy or reduce the sessions to one or fewer per month. Participants were excluded if they needed treatment for substance/alcohol abuse or dependence, were pregnant, had a history of nonresponse or intolerance to the antidepressant study drugs, or required initial use or changes to their antipsychotic medications (for a more detailed summary of inclusion/exclusion criteria, see Miklowitz et al., 2007) . Depending on what arm of the main study they were in, participants were randomly assigned to double-blind pharmacotherapy with mood stabilizers (lithium, valproate, or carbamazepine), placebo plus adjunctive antidepressants (buproprion or fluoxetine), or a combination of mood stabilizer and antipsychotic medications according to patient-physician agreement and guidelines outlined in STEP-BD for best practice evidence-based pharmacotherapy (Sachs et al., 2003) . Included in these analyses is a subset (n = 243; 83%) of randomized participants (n = 293), who provided information both at study entry and throughout study participation regarding their minimum and maximum sleep duration from the past week on the Clinical Monitoring Form (CMF; Sachs et al., 2003) . Trained clinicians, specializing in the assessment of bipolar symptoms, would use weekly milestones, such as work and seeing friends and family, or the day of the week to help them remember the most and least amount of sleep that they had over the past week.
Sleep Functioning Measures
Sleep duration was operationally defined as the average number of hours of sleep in the past week. This average was calculated using the minimum and maximum sleep duration values from the previous week reported on the CMF (Gruber et al., 2009) . Participants were divided into three groups based on their average nightly sleep duration the week before baseline: short sleepers, normal sleepers, and long sleepers. Short sleepers were defined as those with an average of <6 hours of sleep per night, normal sleepers as those with an average 6.5 to 8.5 hours per night, and long sleepers as those with ≥9 hours of sleep per night. These cutoffs have been validated in other studies based on their distinct clinical correlates (Edinger et al., 2000; Gruber et al., 2009; Kaneita et al., 2007) .
Assessment of Treatment Outcomes

Diagnoses and Psychiatric History
Diagnoses of bipolar disorder relied on the consensus of two trained clinicians: a clinical specialist (a psychologist or social worker) who administered the Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998 ) and a psychiatrist who administered a standardized affective disorder evaluation (ADE; Sachs, 1990) . Diagnosis of anxiety disorders relied on the MINI, and psychiatric history (e.g., number of previous bipolar episodes) were captured on the ADE.
Mood Symptoms
During each treatment visit, participants' mood symptoms were assessed using the CMF. Participants reporting ≤2 moderate mood symptoms (depression and mania/hypomania) for ≥8 consecutive weeks were given a clinical status designation of "recovered." Participants were considered "not recovered" if they reported ≥3 depressive or manic/hypomanic symptoms (Sachs et al., 2003) . Interrater reliability coefficients (according to gold standard ratings for depression and mania ratings in the CMF) ranged from 0.83 to 0.99 (intraclass correlations).
Overall Functioning
The Global Assessment of Functioning (GAF) scale is scored on a numeric scale (range: 0 = inadequate information to 100 = superior functioning) and is widely used to rate the social, occupational, and psychological functioning of adults (Hall, 1995) . The modified Global Assessment of Functioning (GAF) scale has more detailed criteria and a more structured scoring system than the original GAF. Scores were based on the judgment of trained study research staff after completing their clinical interview.
Data Analyses
To evaluate whether sleep group (short, normal, or long sleepers) predicted recovery rates and time until recovery, we conducted logistic regression and Cox proportional hazard (survival) models. Participants were included until their final assessment point, which was a maximum of 365 days (M = 166.48, SD = 102.58; Sachs et al., 2003) . To evaluate the ability of sleep group to predict recovery status after adjusting for treatment effects, treatment condition (intensive psychotherapy or collaborative care) was included in the model as an independent variable, and participants who were normal sleepers were compared to short and long sleepers in terms of recovery status. Demographic, mood, and medication variables that differed across sleep groups were entered as predictors into the regression models.
To examine whether sleep disturbance moderated treatment outcome, we added an interaction term with treatment condition to our models predicting recovery rates and time until recovery. We followed Kraemer and Kupfer (2006) recommendations for examining exploratory moderators of treatment outcome in randomized controlled trials, using effect sizes. We examined the magnitude of the treatment effects at each proposed moderator level (Kraemer and Kupfer, 2006) and 95% confidence intervals, as indicated by the Newcombe-Wilson score method without continuity correction (Newcombe, 1998) .
To illustrate the magnitude of effect sizes, we used the Number Needed to Treat (NNT) effect size, which is most robust for examining the clinical significance of binary outcomes (Altman and Andersen, 1999; Cook and Sackett, 1995) . NNT is the number of patients one would expect to treat with the investigational treatment, or intensive psychotherapy, to have one more patient respond to the treatment than if the same number was treated with the control treatment (Deckersbach et al., 2014 ). An NNT value of 2 is considered large, 3.5 is medium, and effect sizes greater than 9 are small (Kraemer and Kupfer, 2006) . We compared short sleepers, normal sleepers, and long sleepers on the magnitude of the between group (collaborative care vs. psychotherapy) Where data points were missing, percentages are calculated out of total number of available cases. Diagnoses were determined using the Affective Disorders Evaluation.
*Difference between short sleepers and long sleepers (p < 0.05). **Difference between short sleepers and normal sleepers (p < 0.05). ***Difference between normal sleepers and long sleepers (p < 0.05). GAF indicates Global Assessment of Functioning; Depressive severity, summary score of depression symptoms [excluding sleep variables] from the Clinical Monitoring Form recorded within 1 week of the date of randomization to treatment; Mania severity, summary score of mania symptoms [excluding sleep variables] from the Clinical Monitoring Form recorded within 1 week of the date of randomization to treatment. effect size. NNT for "recovered" status was examined separately for participants in each sleep group and treatment condition according to the average number of hours they reported sleeping per night at their baseline visit.
Additionally, for each sleep group, a 3 Â 2 Â 2 mixed model analysis of variance (MANOVA) was used to examine the change in sleep duration within subjects and across sleep groups and treatment arms, with sleep group (short sleepers, normal sleepers, and long sleepers) and treatment group (intensive psychotherapy, collaborative care) as the between-subjects factors and study visit (pre-, postintervention) as the within subjects factor. Table 1 shows the demographic and clinical characteristics of the 243 depressed bipolar participants. The average age was 40.32 (SD = 11.47), 60% (n = 146) were female, and 61% (n = 136) had bipolar I disorder. There were no significant differences in demographic and clinical characteristics between our sample and the 50 participants with no CMF sleep data (data not shown).
RESULTS
Study Sample
Psychosocial Treatment Outcome
Participants demonstrated significantly higher year end recovery rates if they were randomly assigned to intensive psychotherapy than collaborative care, χ 2 (1, n = 243) = 4.00, p < 0.05. These findings are consistent with the results found in the full sample (n = 293; Miklowitz et al., 2007) .
Clinical and Demographic Variables by Sleep Group
Out of the 243 participants with baseline sleep data available, 67 were identified as short sleepers, 99 as long sleepers, and 77 as normal sleepers. The subgroups did not differ in sex, education, marital status, bipolar subtype, depressive symptom severity, or having a lifetime anxiety disorder (all p's > 0.18; see Table 1 ). There were differences among the three groups in baseline manic symptom severity, F(2, 242) = 2.95, p = 0.05, and mood stabilizer usage, χ 2 (2, n = 238) = 7.61, p < 0.05. There were statistical trends towards differences in global functioning (GAF) scores, F(2, 235) = 2.69, p = 0.07, atypical antipsychotic usage, χ 2 (2, n = 238) = 4.00, p = 0.07, and anticonvulsant usage, χ 2 (2, n = 238) = 5.43, p = 0.06 (Table 1) .
Pairwise comparisons showed that short sleepers had greater mania severity than long sleepers, t(240, n = 236) = 2.35, p < 0.05. Compared to normal sleepers, short sleepers were significantly more likely to be taking mood stabilizers χ 2 (1, n = 141) = 6.96, p < 0.05, but less likely to be taking atypical antipsychotics χ 2 (1, n = 141) = 4.58, p < 0.05. Normal sleepers were significantly less likely than long sleepers to be taking mood stabilizers χ 2 (1, n = 171) = 5.15, p < 0.05, and anticonvulsants χ 2 (1, n = 171) = 4.96, p < 0.05. Short sleepers were also significantly less likely to take atypical antipsychotics than long sleepers χ 2 (1, n = 164) = 4.04, p < 0.05. Note the varying degrees of freedom are due to missing values. Binary logistical regressions showed that baseline mania severity did not significantly predict recovery rates in any of the sleep groups (all p's > 0.12).
Does Sleep Type Predict Recovery or Time to Recovery?
Logistic and Cox regressions were used to examine predictors of recovery and time to recovery. Treatment group, sleep group, baseline GAF, and medication use (anticonvulsants, atypical antipsychotics, other mood stabilizers) were entered as additional predictors in the models. Results of the modeling sequence are shown in Table 2 . Sleep group (short, long, normal) did not predict likelihood of recovery (p's > 0.41; see Table 2 ) nor time until recovery (p's > 0.57). Higher baseline GAF scores and increased mood stabilizer use (not lithium) Table 2 ).
Moderator Analyses
The treatment interaction terms for sleep group did not reach significance for either model, so sleep group did not moderate recovery or time to recovery (p's > 0.20). Sixty-three percent (n = 25) of short sleepers recovered with intensive psychotherapy, whereas only 41% (n = 11) recovered with collaborative care. This treatment response rate difference resulted in a medium effect size (NNT = 4.55; see Table 3 ). Thus, we would need to treat 4.55 short sleepers with IP rather than collaborative care to have an additional short sleeper recovering with IP. A similar pattern of effects was observed for long sleepers. Seventy percent (n = 35) of long sleepers recovered with psychotherapy, whereas only 51% (n = 25) recovered with collaborative care. This treatment difference resulted in a medium effect size (NNT = 5.26; see Table 2 ). That is, we would need to treat 5.26 long sleepers with IP compared to collaborative care to have an additional long sleeper recover from IP. Finally, 57% of normal sleepers (n = 26) recovered with psychotherapy, and 58% (n = 18) recovered with collaborative care. These recovery rates corresponded to a very small effect size (NNT = 100; see Table 3 ). Table 4 shows the changes in average sleep duration posttreatment for each sleep group. The 3 Â 2 Â 2 MANOVA assessing sleep change as function of baseline sleep group and treatment indicated a significant main effect of sleep group, F(2, 237) = 192.7, p < 0.001, and study visit, F(1, 237) = 8.10, p < 0.01. There was no main effect of treatment group, F(1, 237) = 0.69, p = 0.41, indicating that sleep duration did not differ for intensive psychotherapy and collaborative care. There was a significant study visit by sleep group interaction, F(2, 237) = 87.92, p < 0.001, indicating that change in sleep duration varied according to sleep group over the treatment phase. Sleep duration pre-to post-intervention increased for short sleepers (M Pre-= 4.94, M Post-= 6.72), decreased for long sleepers (M Pre-= 10.84, M Post-= 8.24), and did not change for normal sleepers. There was no study visit by treatment group interaction, indicating that change in sleep duration over treatment did not vary according to treatment condition. There was also no study visit by treatment group by sleep group interaction, or sleep group by treatment group interaction.
Changes in Sleep with Treatment
DISCUSSION
The present study investigated whether sleep disturbance serves as a predictor and/or a moderator of psychotherapy response in depressed individuals with bipolar disorder. Sleep neither predicted the likelihood of recovery nor the time to recovery in our analyses. Contrary to our hypothesis, receiving intensive psychotherapy as opposed to collaborative care did not offer a major advantage in terms of recovery rates. This is somewhat surprising, as individuals with bipolar disorder who are poor sleepers may experience more stressors in their lives or have less ability to manage the stressors, which would be addressed in intensive psychotherapy, but not collaborative care. This hypothesis is consistent with previous studies indicating that stressful life events can have a negative impact on sleep quality (Bernert et al., 2007; Frank et al., 2000; Haynes et al., 2006) . Noteworthy shortcomings of the present study included that sleep duration was assessed by selfreport, which is vulnerable to recall bias, and the study did not include objective measures of sleep quantity or quality such as polysomnography or actigraphy (Fernandez-Mendoza et al., 2011; Mercer et al., 2002) . Therefore, it is not possible to formally diagnose individuals with insomnia or hypersomnia. Future research should utilize objective measures or daily sleep diaries to provide more data on weekly sleep patterns. Randomization to treatment group was not stratified according to sleep type, possibly confounding our finding of sleep on recovery. Of note, this study also does not examine the role of sleep on mania or hypomania on treatment response as participants were only enrolled if depressed at baseline. Further, due to sample size restrictions, we did not investigate the differential effects of the type of psychotherapy, which consisted of three treatments. Therefore, it is possible that the extent to which sleep was emphasized differed depending on the treatment modality received. Future research should more closely examine whether sleep patterns influence response to psychotherapy differentially depending on type of services. Lastly, the measure of sleep only covered the previous past week, and it would be useful to know if habitual long-term sleep patterns had a similar relationship. Furthermore, it is possible that sleep variability rather than sleep 
